Markus HAAKE

City:

Estenfeld

Country:

Germany

Published Applications:

Last publication date:

2026-05-21

Top Assignees for applications by Markus HAAKE

The entities that hold a legal rights for patent applications filed by inventor HAAKE Markus:

JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG 4 Würzburg, Germany
CatalYm GmbH 1 Planegg-Martinsried, Germany
JULIUS-MAXIMILIANS-UNIVERSITÄT WURZBURG 1 Wurzburg, Germany

Recent patent applications by HAAKE Markus

Markus HAAKE from Estenfeld, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-21

US20260140123A1

Physics

GDF-15 AS A DIAGNOSTIC MARKER TO PREDICT THE CLINICAL OUTCOME OF A TREATMENT WITH IMMUNE CHECKPOINT BLOCKERS

#2 | 2026-02-26

US20260055172A1

Chemistry; metallurgy

ANTI-GDF15 ANTIBODY AND A DOSAGE REGIMEN FOR THE TREATMENT OF CANCER

#3 | 2025-09-11

US20250282858A1

Chemistry; metallurgy

ANTI-GDF15 ANTIBODY AND A DOSAGE REGIMEN FOR THE TREATMENT OF CANCER

#4 | 2024-02-08

US20240043517A1

Chemistry; metallurgy

ANTI-GDF15 ANTIBODY AND A DOSAGE REGIMEN FOR THE TREATMENT OF CANCER

#5 | 2023-03-23

US20230093412A1

Human necessities

COMBINATION THERAPY USING INHIBITORS OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15) AND IMMUNE CHECKPOINT BLOCKERS

#6 | 2022-08-04

US20220242942A1

Chemistry; metallurgy

GDF-15 AS A DIAGNOSTIC MARKER TO PREDICT THE CLINICAL OUTCOME OF A TREATMENT WITH IMMUNE CHECKPOINT BLOCKERS

#7 | 2019-05-30

US20190160169A1

Human necessities

Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

#8 | 2019-01-03

US20190000955A1

Human necessities

Targets of

#9 | 2018-10-11

US20180292412A1

Physics

GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers

InventorID:

2319912 ⎘